Avolon selects CFM LEAP engines to power new A320neo fleet

— Avolon places a firm order for 100 CFM LEAP-1A engines to power 50 Airbus A320neo family aircraft Avolon, one of the world's leading aircraft leasing companies, today announced a firm order for 100 CFM LEAP-1A engines to equip 50 new Airbus A320neo family aircraft. https://mma.prnewswire.com/media/2824721/CFM_International_Avolon.jpg Avolon has been a CFM customer since 2010 and […]

GEP Recognized in the 2025 Gartner ® Magic Quadrant ™ for Contract Lifecycle Management (CLM)

GEP®, a provider of AI-powered procurement and supply chain software for Fortune 500 and Global 2000 enterprises worldwide, today announced that Gartner has recognized GEP SOFTWARE™ in the 2025 Magic Quadrant™ for Contract Lifecycle Management (CLM). Download a complimentary copy of Gartner Magic Quadrant for CLM, which evaluated 16 providers based on their Completeness of

Artists & Robots Launches; Returns Human Creative to an AI-Fueled World

New studio balances responsible innovation with brand impact that feels distinctly human Artists & Robots, an independent brand experience studio founded to amplify human creativity in an AI-powered world, today announced its launch in New York. The studio, led by co-founders Heather Salkin and Jason Alan Snyder, provides a full range of services to invent

CarMax, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – KMX

(NYSE:KMX), LOS ANGELES, Nov. 17, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who

Curcumin Market Size to Hit USD 301.79 Million by 2034 with a Strong 11.8% CAGR

Curcumin Market Size to Hit USD 301.79 Million by 2034 with a Strong 11.8% CAGR According to Towards FnB, the global curcumin market size is calculated at USD 110.59 million in 2025 and is anticipated to surge USD 301.79 million by 2034, growing at impressive CAGR of 11.8% from 2025 to 2034. This upward trajectory

CarMax, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – KMX

CarMax, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – KMX GlobeNewswire November 17, 2025 LOS ANGELES, Nov. 17, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) violations of §§10(b) and

Winthrop Wealth Named to Inc.’s 2025 Best Workplaces List

Annual list recognizes the businesses that set the standard for workplace success and awards excellence in company culture Winthrop Wealth is thrilled to announce its inclusion onInc. magazine's 2025 Best Workplaces list, which honors companies that foster exceptional workplace cultures and prioritize the well-being of their employees. https://mma.prnewswire.com/media/2549537/WW_Logo.jpg The annual list, featured on Inc.com, recognizes

Honda Powers the Dreams of Team USA Athletes as They Go for Gold in Milano Cortina

— Meet Team Honda: 10 Team USA athletes serving as official Honda ambassadors for the Olympic andParalympic Winter Games Milano Cortina 2026 — Honda is the Official Automotive Partner of Team USA, supporting the United States Olympic andParalympic Teams during Milano Cortina 2026 and the LA28 Games Honda today announced the selection of 10 inspiring

Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization

Anixa Biosciences, Inc.(“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization (WHO) approved “liraltagene autoleucel” for the non-proprietary name of the Company's novel FSHR-targeted CAR-T therapy for recurrent ovarian cancer. The INN

Levi & Korsinsky Releases SueWallSt Podcast on James Hardie Industries plc. (JHX) Lawsuit

NEW YORK, NY / ACCESS Newswire / November 17, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding James Hardie Industries plc. (NYSE:JHX) class action securities lawsuit A Class Action lawsuit was filed on behalf of James Hardie Industries plc. investors who lost money as a result of alleged securities fraud between May 20,

Scroll to Top